Upstream Bio (UPB) Other Accumulated Expenses (2024 - 2025)
Upstream Bio (UPB) recorded quarterly Other Accumulated Expenses of $55000.0 in Q3 2025, down 53.39% quarter-over-quarter from $118000.0 in Q3 2024, and down 53.39% on a YoY basis from $118000.0 in Q3 2024.
Upstream Bio (UPB) Other Accumulated Expenses (2024 - 2025) Analysis & Trends
Upstream Bio's Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $55000.0 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Upstream Bio | 339.03 Mn | 339.03 Mn | -3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 55,000.00 |
| Sep 30, 2024 | 118,000.00 |